Plasmagen Biosciences Profile
Key Indicators
- Authorised Capital ₹ 90.39 Cr
as on 19-06-2024
- Paid Up Capital ₹ 87.53 Cr
as on 19-06-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 200.25 Cr
as on 19-06-2024
- Satisfied Charges ₹ 20.55 Cr
as on 19-06-2024
- Revenue 17.51%
(FY 2022)
- Profit -89.29%
(FY 2022)
- Ebitda 10.95%
(FY 2022)
- Net Worth 49.81%
(FY 2022)
- Total Assets 94.09%
(FY 2022)
About Plasmagen Biosciences
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 90.39 Cr and a paid-up capital of Rs 87.53 Cr.
The company currently has active open charges totaling ₹200.25 Cr. The company has closed loans amounting to ₹20.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Plasmagen Biosciences Private Limited India is Arjun Rajagopal as COMPANY SECRETARY. Vinod Nahar, Gopal Sarda, Rahul Jain, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51909KA2010PTC055077
- Company No.
055077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Plasmagen Biosciences Private Limited offer?
Plasmagen Biosciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, Anti Cancer Medicines, Human Albumin Injection, TB, Tumor & Cancer Drugs, Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection, Immunization & Vaccination Drugs, Vaccines.
Who are the key members and board of directors at Plasmagen Biosciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Nahar  | Managing Director | 07-Sep-2010 | Current |
| Arjun Rajagopal | Company Secretary | 18-Mar-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prem Pavoor | Director | 28-Jul-2017 | Current |
| Gopal Sarda | Director | 07-Jul-2017 | Current |
| Rahul Jain | Director | 31-Mar-2015 | Current |
Robert Weisskoff  | Director | 28-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Plasmagen Biosciences.
Plasmagen Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.51% increase. The company also saw a substantial fall in profitability, with a 89.29% decrease in profit. The company's net worth Soared by an impressive increase of 49.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plasmagen Biosciences?
In 2022, Plasmagen Biosciences had a promoter holding of 79.45% and a public holding of 20.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eight Roads Investment Advisors Private LimitedActive 17 years 5 monthsPrem Pavoor is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Jun 2022 | ₹20.00 Cr | Open |
Others Creation Date: 31 Mar 2022 | ₹2.52 M | Open |
Sbicap Trustee Company Limited Creation Date: 29 Mar 2021 | ₹165.00 Cr | Open |
How Many Employees Work at Plasmagen Biosciences?
Plasmagen Biosciences has a workforce of 262 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plasmagen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plasmagen Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
